Topics
Glioblastoma | Etiopathogenesis | Hypoxia
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Hypoxia
Begagić
E, Bečulić H, Džidić-Krivić A, Kadić
Vukas S, Hadžić S, Mekić-Abazović A, Šegalo
S, Papić E, Muchai Echengi E, Pugonja R, Kasapović T,
Kavgić D, Nuhović A, Juković-Bihorac F, Đuričić
S, Pojskić M.
Understanding
the Significance of Hypoxia-Inducible Factors (HIFs) in
Glioblastoma: A Systematic Review.
Cancers
(Basel).
2024 May 30;16(11):2089. doi:
10.3390/cancers16112089. PMID:
38893207.
Review. ˍ
Feldman L.
Hypoxia within the
glioblastoma tumor microenvironment: a master saboteur of novel
treatments.
Front
Immunol. 2024 Jun 26;15:1384249. doi:
10.3389/fimmu.2024.1384249. PMID:
38994360. Review. ˍ
Bou-Gharios J, Noël G, Burckel H.
Preclinical
and clinical advances to overcome
hypoxia in glioblastoma multiforme.
Cell
Death Dis. 2024 Jul 13;15(7):503. doi:
10.1038/s41419-024-06904-2. PMID:
39003252.
Review. ˍ